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Dengue virus (DENV) infection induces the expansion
of plasmablasts, which produce antibodies that
can neutralize DENV but also enhance disease upon
secondary infection with another DENV serotype. To
understand how these immune responses are gener-
ated, we used a systems biological approach to
analyze immune responses to dengue in humans.
Transcriptomic analysis of whole blood revealed
that genes encoding proinflammatory mediators
and type I interferon-related proteins were associ-
ated with high DENV levels during initial symptom-
atic disease. Additionally, CD14+CD16+ monocytes
increased in the blood. Similarly, in a nonhuman pri-
mate model, DENV infection boosted CD14+CD16+
monocyte numbers in the blood and lymph nodes.
UponDENV infection in vitro,monocytes upregulated
CD16 and mediated differentiation of resting B cells
to plasmablasts as well as immunoglobulin G (IgG)
and IgM secretion. These findings provide a detailed
picture of innate responses to dengue and highlight
a role for CD14+CD16+ monocytes in promoting
plasmablast differentiation and anti-DENV antibody
responses.
INTRODUCTION
Dengue is an emerging, mosquito-borne infectious disease that
causes clinical disease in nearly 100 million people annually
(Bhatt et al., 2013). Infection with one of the four serotypes of
DENV can result in dengue fever (DF), dengue hemorrhagic fever
(DHF), or dengue shock syndrome (DSS), which is a life-threat-
ening illness (Simmons et al., 2012). The initial targets of DENV
infection in vivo are poorly understood, althoughDENV can infectCellskin resident Langerhans cells (LCs) (Wu et al., 2000), mono-
cytes, macrophages (MQs), dendritic cells (DCs) (Durbin et al.,
2008; Ho et al., 2001; Wu et al., 2000), and endothelial cells
in vitro (Bosch et al., 2002). Consistent with this, recent studies
implicate molecules commonly expressed on myeloid cells,
such asDC-SIGN (Tassaneetrithep et al., 2003), mannose recep-
tor (MMR) (Miller et al., 2008), and TIM and TAM proteins (Meert-
ens et al., 2012), as receptors for DENV entry, and CLEC5A was
shown to directly interact with DENV to promote inflammatory
response (Chen et al., 2008). DENV infection can be also medi-
ated by interactions of the virus-Ab complexes with Fc-g recep-
tors during secondary infection with a heterologous serotype
(Boonnak et al., 2008; Halstead and O’Rourke, 1977).
Another characteristic feature of dengue infection is the
massive expansion of antibody-producing plasmablasts in the
blood, which occurs within a few days of infection (Balakrishnan
et al., 2011; Garcia-Bates et al., 2013; Wrammert et al., 2012).
However, although infection with a given serotype can induce
antibodies that are cross-reactive to the other serotypes, gener-
ally long-term immunity is generated only against the original
serotype (Green and Rothman, 2006). In fact, in many cases, im-
munity against a heterologous serotype is not protective butmay
augment the severity of disease (Burke et al., 1988; Guzma´n
et al., 2000; Sangkawibha et al., 1984), possibly through amech-
anism termed antibody-dependent enhancement (ADE) (Hal-
stead et al., 2010). Although it is clear that both the virus strain
and the immune response play a role in disease outcome, the
specific mechanisms that lead to protective versus nonprotec-
tive immune responses or mild versus severe disease are poorly
understood.
Monocytes, the most abundant blood mononuclear phago-
cytes and one of the main cell targets of DENV (Durbin et al.,
2008), originate from myeloid precursors in bone marrow and
differentiate into tissue MQs and DCs (Auffray et al., 2009). In
fact, human blood monocytes represent a diverse group of cells
that can be distinguished by their phenotype and function into at
least three populations (Saha andGeissmann, 2011; Ziegler-Heit-
brock andHofer, 2013). The ‘‘classical’’ CD14+CD16monocytesHost & Microbe 16, 115–127, July 9, 2014 ª2014 Elsevier Inc. 115
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ity to the mouse Gr1+Ly6Chi monocytes and respond to CCL2
(MCP-1) that signals via CCR2 (Ingersoll et al., 2011). CD14+
CD16 monocytes produce interleukin-10 (IL-10) as well as IL-
6, IL-8, CCL2 (MCP-1), and RANTES upon lipopolysaccharide
(LPS) stimulation (Cros et al., 2010; Serbina et al., 2009; Wong
et al., 2011); in contrast, the ‘‘intermediate’’ CD14+CD16+ mono-
cytes can sense ligands for Toll-like receptor 2 (TLR2), TLR4,
as well as TLR8 and secrete IL-6, IL-8, CCL2 (MCP-1),
CXCL10 (IP-10), IL-1b, and tumor necrosis factor alpha (TNF-a)
(Cros et al., 2010; Wong et al., 2011). The ‘‘nonclassical’’
CD14dimCD16++ resemble murine Gr1Ly6Clo cells, express
CX3CR1, can detect viral RNA via TLR7 and TLR8, and are pre-
dominant producers of IL-1b, TNF-a, and CXCL10 (IP-10) (Cros
et al., 2010; Wong et al., 2011).
Here, we used an integrated approach to obtain a detailed
picture of the innate response during the acute dengue. Our
transcriptional profiling and immunological analysis of clinical
dengue patients, together with results from a nonhuman primate
(NHP) model of DENV infection and in vitro experiments, sug-
gest a distinctive role of CD14+CD16+ monocytes in mediating
humoral immunity to DENV infection.
RESULTS
Transcriptional Signatures Correlate with DENV Viral
Loads and Duration of Illness but Do Not Discriminate
between DF and DHF
We analyzed whole-blood samples from 28 secondary dengue
patients (DF, n = 18; DHF, n = 10) hospitalized at the Siriraj Hos-
pital in Bangkok, Thailand during the 2009 season. A single blood
collection was acquired between days 2 and 9 after onset of
symptoms (acute illness) as reported by patients at admission
and for 19 patients (DF, n = 13; DHF, n = 6) also at the convales-
cence at 4 weeks or later after discharge (Figure 1A). Addition-
ally, blood was sampled from nine local, healthy, young adults
to provide controls for transcriptomic and immunological
analysis (full characteristic of the cohorts can be found in the
Supplemental Information and Tables S1 and S2). Among the
patients there was a considerable variation in the viral load (VL,
from <100 to 9.37 3 109 copies/ml) and concentration of
DENV NS-1 antigen in plasma (Figure 1B). The VL and NS-1 an-
tigen concentrations were positively correlated with each other
(Figure 1B) and correlated inversely with the duration of acute
illness (Figure 1C), with the highest VL and NS-1 concentration
at early illness between 2 and 4 days of symptomatic dengue
for both DF and DHF patients (Figure 1C).
Gene microarrays were used to assess the whole-blood tran-
scriptome of 28 acute patients, 19 convalescents, and 9 healthy
controls. Our initial unsupervised analysis using the 7,528 genes
with highest variance demonstrated that samples from the
acutely infected patients, including both DF and DHF patients,
clustered differently from the convalescent and control individ-
uals. However, within the acutely infected patients we observed
large heterogeneity of gene expression patterns as classified by
either hierarchical clustering (Figure 1D) or principal component
analysis (PCA; Figure S1A, available online). Furthermore, no
defined clusters between acute DF and DHF patients could be
detected (Figure 1D). Instead, we observed two distinct clusters116 Cell Host & Microbe 16, 115–127, July 9, 2014 ª2014 Elsevier Inthat were related to VL and NS-1 concentration at the early stage
of symptomatic illness (Figure 1E). A group of five patients
with the highest VL (VL > 107) and NS-1 concentrations formed
a distinct cluster from those patients with lower viremia (VL <
105) (Figures 1D and 1E). Thus, transcriptional profiling could
clearly discriminate between patients with acute dengue and
convalescent or control subjects, as well as those with high
versus low VL, but not between DF and DHF.
Distinct Molecular Pathways Discriminate between
Subjects with High versus Low Viral Loads and Early
versus Late Disease
The blood transcriptome in dengue patients can be dependent
on both the disease duration and VL (Popper et al., 2012; Sun
et al., 2013). To determine molecular pathways associated with
VL or disease duration, we first performed Pearson’s correlation
analysis between all 18,146 genes and the VL (Figure 2A) or days
of symptomatic illness (Figure S1B) in the 28 acute dengue pa-
tients. Pathway enrichment analyses were performed using
the 1,000 genes with the highest positive (high VL) or negative
(low VL) correlation (Figures 2B–2E). Genes associated with the
innate sensing of viruses and inflammatory responses to viral
infection were positively correlated with high VL (107–109
copies/ml; Figure 2B and Table S3) and inversely correlated
with duration of illness (Figure S2C). Similar results were estab-
lished by analyzing the VL-scored specimens by gene set enrich-
ment analysis (GSEA) using the Reactome database (Table S4).
Genes with the highest correlation to VL and early symptomatic
disease were associated with the upstream regulation of type I
interferon (IFN) signaling (Figure 2C). The top 1,000 genes whose
expression was negatively correlated with VL (i.e., highly ex-
pressed in patients with low or undetectable VL; Figure 2D) at
the late stage of illness (Figure S1D) were associated with path-
ways involved in cell cycle, proliferation, cell metabolism, and
translational control (Figures 2D and S1D and Tables S3 and S4).
The fact that molecular pathways that directly correlate with VL
are inversely correlated with the duration of illness is consistent
with the reciprocal relationship between VL and disease duration
(Figure 1C). However, to determine the impact of VL on transcrip-
tional profiles, at a given time during the disease we compared
gene signatures between patients with high VL versus low VL
enrolled during the first 2–4 days of symptoms (Figure S1F).
Distinct innateand inflammatory immunepathwayswereenriched
in high versus lowVLpatients (Figures S1GandS1H) even at early
illness (Figures 2B and 2D), suggesting that the VL can impact the
transcriptional profiles independently of disease duration.
Additional analysis revealed a significant enrichment of XBP-1
target genes among the genes highly expressed in patients with
low VL (Figure 2E). XBP1 is a transcription factor that mediates
the unfolded protein response and is involved in the differen-
tiation of plasma cells (Reimold et al., 2001). The signature of
XBP-1 activation was consistent with increased numbers of
plasmablast cells (Figure S2A), which correlated with the dura-
tion of illness (Figure S2B). Enhanced numbers of plasmablasts
has been previously observed with dengue infections (Wram-
mert et al., 2012) and in humans vaccinated with the influenza
vaccine (Nakaya et al., 2011).
Finally, we used GSEA to identify immune cell types in blood
of dengue patients. We detected significant enrichment in genesc.
Figure 1. The Transcriptional Response Induced by Dengue Infection Is Correlated with Viral Load
(A) Clinical study design.
(B) VL and NS-1 antigen concentration in plasma from acute dengue patients. Correlation analysis shows formation of two distinct groups with high (VL > 107,
n = 23) and low (VL < 105, n = 5) viral burden.
(C) Correlation analysis of VL (left) and NS-1 Ag concentration (right) with days of dengue illness at the specimen collection.
(D) Unsupervised clustering analysis.
(E) Reported days of illness at collection andmatching VL (red bars) and NS-1 Ag (blue bars) corresponding to the individual dengue patients on the heatmap. DF,
n = 18: black dots; DHF, n = 10: red dots.
See also Figure S1 and Tables S1 and S2.
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imens with high VL (Figure 2F) at the early stage of acute dengue
(Figure S1E). In contrast, patients at the late stage of symptom-
atic dengue with low VL were associated with genes expressed
specifically in NK cells, CD4+ and CD8+ T cells, as well as B cells
(Figures 2F and S1E). Thus, these data reveal enrichment in the
innate immune pathways in patients with high viral burden at the
early phase of infection. Gene signatures specific for innate cells,
including monocytes, DCs, and MQs, were associated with high
VL and early illness.
DENV Infection Induces a Cellular, Transcriptional, and
Cytokine Signature of CD14+CD16+ Monocytes in Blood
Alterations in blood cells during acute dengue were dependent
on the VL and duration of the symptomatic disease (Figure S2CCelland Table S2). Hence, we evaluated the innate cell populations
by flow cytometry (Figure S3A). DENV infection increased the
frequency of blood monocytes, especially in high VL patients
(Figure 3A); however, we did not detect a significant increase in
absolute numbers of monocytes (Figure S3B). In contrast, there
was a striking reduction in the proportion and absolute numbers
of the BDCA-1+ mDC-1 population in individuals with high VL at
the early stage of illness (Figures 3A, S3B, and S3C). Low
numbers of the mDC-1 correlated with the duration of disease
(Figure S3C). Similar trends were also evident with basophils,
but not with the cross-presenting BDCA-1neg mDC-2 subset or
pDCs and natural killer (NK) cells (Figures 3A, S3B, and S3C).
The change in the frequency of blood monocytes was
consistent with the enrichment of monocyte-associated genes
in the transcriptional signature (Figures 2F and S1E); therefore,Host & Microbe 16, 115–127, July 9, 2014 ª2014 Elsevier Inc. 117
Figure 2. Transcriptomic Analysis Identifies Molecular Networks that Correlate with DENV Viral Load
(A) Heatmap of probe sets (rows) and subjects (columns) ranked by VL (top); colors in the map indicate relative gene expression. Right margin: probe sets with
negative (blue) or positive (red) correlation to VL. p < 0.05 (Pearson). Frames: approximate range of top 1,000 genes positively (red) or negatively (blue) correlated
to VL used for analysis in (B)–(E).
(B) Top Ingenuity pathways that positively correlate with VL. Dotted line represents a cutoff value (log p = 2).
(C) IPA analysis of positively VL-correlated genes regulated by IFN-a. p < 0.05 (Pearson).
(D) Top Ingenuity pathways that negatively correlate with VL. Dotted line represents a cutoff value (log p = 2).
(E) IPA analysis of negatively VL-correlated genes regulated by XBP-1. p < 0.05 (Pearson).
(F) GSEA analysis of the whole-blood transcriptome of acute dengue patients using cell-specific data sets. Normalized enrichment score (NES) indicates positive
(NES > 0, red bars) or negative (NES < 0, blue bars) correlation of distinct cell-specific gene sets to VL.
See also Figures S1 and S2 and Tables S3 and S4.
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using monocyte-specific data sets (Cros et al., 2010) to discrim-
inate monocytes-specific signatures. GSEA analysis determined
a significant enrichment in genes specific for the intermediate
CD14+CD16+ monocytes in acute dengue (Figure 3B). This is
consistent with the enhanced frequency of the CD14+CD16+
subset as measured by flow cytometry (Figures 3C and 3D).
Consistent with the inverse correlation between VL and disease
duration (Figure 1C), the expansion of CD14+CD16+ cells corre-
lated with early disease (data not shown).
Acute infection induced secretion of plasma proinflammatory
chemokines IP-10 (CXCL-10), MCP-1 (CCL-2), MIP-1b (CCL-
4), and IL-1ra (Figure 4A), notably in patients with high VL and
the early stage of disease (data not shown). Interestingly, levels
of IP-10 and MIP-1b correlated with the frequency and absolute118 Cell Host & Microbe 16, 115–127, July 9, 2014 ª2014 Elsevier Innumbers of the CD14+CD16+ cells in blood (Figure 4B). Addition-
ally, we detected a substantial quantity of IL-10, eotaxin (CCL-
11), IL-6, and IL-8; however, there was no significant correlation
to VL (Figure 4A). In summary, acute dengue results in an expan-
sion of the CD14+CD16+ monocytes, depletion of the BDCA-1+
mDCs and basophils, and an increase in plasma proinflamma-
tory cytokines. This was most pronounced within patients with
viral burden at the early stage of dengue.
DENV-Infected Blood Monocytes Differentiate into
CD14+CD16+ Cells, which Induce the Differentiation of
Resting B Cells into Plasmablasts
The rapid kinetics of expansion of the CD14+CD16+ monocyte
subset in dengue raised the possibility that such cells may
modulate the immune response to DENV infection. Infection ofc.
Figure 3. DENV Infection Enhances the Frequency of CD14+CD16+ Monocytes in Blood
(A) Proportions of innate cell subsets within white blood cells (WBCs).
(B) GSEA analysis of the whole-blood transcriptome of the acute dengue patients and healthy individuals (convalescent and controls) using CD14+CD16,
CD14+CD16+, and CD14dimCD16++ cell-specific gene sets. NES: overrepresentation of each of the monocyte subset in dengue or healthy cohorts. False dis-
covery rate (FDR) is indicated as q.
(C) Dot plots show blood monocytes in a representative patient during acute dengue and convalescence. Pie charts represent mean proportions of the
CD14+CD16 (blue), CD14+CD16+ (red), and CD14dimCD16++ (green) cells within all monocytes in acute dengue patients and healthy individuals.
(D) Proportions (top) and absolute counts (bottom) of the monocyte subsets in blood. Absolute counts comprise only convalescent subjects in the healthy cohort.
In (A) and (D), data were compared between dengue patients with high VL (VL > 107, n = 5), low VL (VL < 105, n = 23), and healthy (convalescent, n = 19; controls,
n = 9). Acute dengue: DF, black dots; DHF, red dots. Convalescent: DF, black circles; DHF, red circles. Controls, crossed circles. See also Figures S2 and S3 and
Table S2.
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the fraction of CD14+CD16+ cells to over 70% of all monocytes
(Figure 5A). Similar results were seen with the TLR7/TLR8 ligandCell(R-848), but not TLR4-L (LPS) (Figure 5A). A fraction of the
CD14+CD16+, DENV-infected monocytes demonstrated high
expression of the MQ-associated markers CD206 (MMR) andHost & Microbe 16, 115–127, July 9, 2014 ª2014 Elsevier Inc. 119
Figure 4. Inflammatory Cytokines in Plasma of Acute Dengue Patients Correlate with the Numbers of CD14+CD16+ Monocytes
(A) Cytokines in plasma from patients with acute dengue (DF, black dots; DHF, red dots), convalescent (DF, black circles; DHF, red circles), and controls (crossed
circles) compared between groups of dengue patients with high VL (VL > 107, n = 5), low VL (VL < 105, n = 22), and healthy (convalescent, n = 19; controls, n = 9).
(B) Correlation analysis of plasma concentration of MIP-1b (top) and IP-10 (bottom) with a proportion (top) and absolute counts of CD14+CD16+ monocytes in
blood (bottom).
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Monocyte Stimulation of Plasmablasts during DengueCD115 (M-CSFR), and all of the DENV-infected monocytes ex-
pressed CCR5 as well as high CD163 and CD169 (Figure 5B).
Moreover, electron microscopy imaging demonstrated the pres-
ence of dendrites and large numbers of cytoplasmic vacuoles,
similar to the cells cultured with M-CSF in monocytes infected
with DENV (Figure 5C). In vitro infection of monocytes with
DENV induced secretion of MCP-1 (CCL-2), IP-10 (CXCL-10),
IL-6, IL-8, and IL-10; however, no IL-1b secretion was evident
postinfection with DENV (Figure 5D).
To evaluate the potential functions of these cells, we tested if
blood monocytes infected with DENV can stimulate B cells
in vitro. We infected monocytes or monocyte-derived DCs
(MDDCs) with DENV at multiplicity of infection (moi) = 1 for
48 hr and cultured them with allogenic, resting CD19+ B cells
in the presence of IL-2 and CpG (Figures 5E–5G). After 6 days
of coculture, monocytes infected with DENV stimulated robust120 Cell Host & Microbe 16, 115–127, July 9, 2014 ª2014 Elsevier Inproliferation of B cells as measured by CFSE dilution, but with
efficacy comparable to that of MDDCs (Figure 5E, top panel).
In the monocyte/DENV and B cells coculture, the dividing B cells
expressed CD19 and downregulated CD20, characteristic
of differentiating plasmablasts (Wrammert et al., 2012) (Fig-
ure 5E, bottom). In fact, a 6-day coculture of B cells with infected
monocytes induced a major increase in the frequency of
CD27++CD38++ plasmablasts (Figure 5F) predominantly within
the proliferating B cells (Figure 5F, bottom). Differentiation of
the CD27++CD38++ cells facilitated by monocytes was consider-
ably larger than that stimulated by MDDCs or B cells without
any antigen-presenting cells (APCs) (Figure 5F). Commensurate
with the increase in CD27++CD38++ plasmablast differentiation,
DENV-infected monocytes stimulated secretion of IgG and IgM
(but not IgA) to a level significantly higher than that of MDDCs
or controls (Figure 5G).c.
Figure 5. DENV-Infected Monocytes Acquire CD14+CD16+ Phenotype and Stimulate Plasmablast Differentiation In Vitro
(A) CD14 and CD16 expression in monocytes infected with DENV-2 at the moi = 1, moi = 0.1, or stimulated with LPS or R-848.
(B) Histograms show surface phenotype of unstimulated monocytes (black), monocytes cultured in medium (green), or DENV-2 at moi = 1 (red), isotype (gray).
(C) Electron microscopy images of representative cells from monocyte cultured for 3 days with DENV-2 at moi = 1 or with GM-CSF + IL-4 or M-CSF. Bars, 1 mm.
(D) Cytokines in supernatants of monocytes cultured in medium or with DENV-2 (moi = 1) or R-848 for 48 hr.
(E) Histograms (top) show B cell proliferation measured by CFSE dilution after 6 days. Expression of CD19 (center) or CD20 (bottom) in cultured B cells. Numbers:
percent of proliferated cells. Bar graph: percent of proliferated B cells measured by CSFE dilution; mean ± SEM (four experiments).
(F) CD27++CD38++ plasmablast differentiation within total (top) and proliferated (bottom) B cells after 6 days. Bar graphs: percent of CD27++CD38++ plasmablasts
within total (top) and proliferated (bottom) B cells; mean ± SEM (four experiments).
(G) Titers of IgG, IgM, and IgA in cultures on day 6.
In (A), (B), (D), and (G), data are shown from one representative experiment out of four independent tests with four different blood donors. See also
Figures S4 and S5.
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CD14+CD16+ monocytes stimulate plasmablast differentia-
tion. Interestingly, the expression of genes encoding BAFF and
APRIL, molecules that induce B cell differentiation and survival
(Litinskiy et al., 2002; Mackay and Schneider, 2009), was
increased in the blood of patients with high viremia (Figure S4A)
at the early stage of illness (Figure S4B) and correlated with the
magnitude of theCD14+CD16+monocytes in blood (Figure S4C).
There was a trend for enhanced levels of APRIL protein in the
plasma of dengue patients with high VL (Figure S4D), and consis-
tent with this, monocytes secreted BAFF and APRIL in vitro after
DENV infection (Figure S4E). We blocked BAFF and APRIL
signaling to explore mechanisms of induction of Ab-producingCellplasmablast by monocytes (Figure S5). Anti-BAFF and TACI-Fc
modestly diminished B cell proliferation and differentiation of
plasmablasts (Figures S5A and S5B), and TACI-Fc significantly
reduced production of IgM in vitro (Figure S5C). Furthermore,
we also blocked IL-6, IL-10, and IP-10 in monocyte/B cell
cocultures (Figure S5). Both a-IL-10 and a-IP-10 reduced B
cell proliferation (Figure S5A), but only a-IL-10 significantly
blocked plasmablast differentiation and IgM secretion (Figures
S5B and S5C). These results demonstrated in vitro that DENV
induces differentiation of monocytes to CD14+CD16+ cells,
with a distinct phenotype and morphology that possess a supe-
rior ability to stimulate resting B cells to differentiate into plasma-
blasts via BAFF/APRIL and IL-10.Host & Microbe 16, 115–127, July 9, 2014 ª2014 Elsevier Inc. 121
Figure 6. DENV Infection Induces the Phenotype of CD14+CD16+ Monocytes in Rhesus Macaques
(A) NHP study design.
(B) Images of hemorrhagic manifestation in three representative animals on days 5 and 7.
(C) VL and IgM in plasma.
(D) Proportions of innate cells within total PBMCs.
(E) Dot plots: CD14 andCD16 expression in bloodmonocytes. Pie charts: mean proportions of the CD14+CD16 (blue), CD14+CD16+ (red), CD14CD16 (green),
and CD14dimCD16++ (gray) cells within the total monocytes in all animals.
(F) Kinetics of CD14+CD16+ monocytes within total PBMCs.
In (C), (D), and (F), symbols and lines show individual animals in the cohort. In (D) and (F), t test was used. See also Figure S6.
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Monocyte Stimulation of Plasmablasts during DengueDENV Infection in Macaques Results in Expansion of the
CD14+CD16+ Monocyte Subset in Secondary Lymphoid
Organs
Finally, we used an NHP model of dengue (Onlamoon et al.,
2010) to test if DENV infection also induces expansion of the
CD14+CD16+ monocyte subset in the secondary lymphoid
organs, the sites where interaction with B cells might occur.
We infected a cohort of five rhesus macaques intravenously
with a high dose of DENV-2 (Figure 6A) and sampled blood at
7 days prior to the infection (baseline), at 5 hr, and on days 1,
3, 5, 7, 14, and 28 after challenge.122 Cell Host & Microbe 16, 115–127, July 9, 2014 ª2014 Elsevier InConsistent with the previous report (Onlamoon et al., 2010), an-
imals infectedwithDENV-2 developed skin hemorrhagicmanifes-
tations includingcoagulopathy (Figure6B). Also,DENV infection in
rhesus animals transiently reduced the absolute counts of white
blood cells (WBCs), predominantly within the peripheral blood
mononuclear cells (PBMCs) (Figure S6A). In all the infected
animals, DENV was detectable in plasma between 5 hr and
14 days after infection, though the VL kinetics differed consider-
ably among the individual monkeys (Figure 6C). However, all
the macaques developed DENV-2-specific IgM antibody titer
(Figure 6C). Hence, we were able to efficiently infect nonhumanc.
Figure 7. DENV Infection in Rhesus
Macaques Stimulates Enhanced Numbers
of the CD14+CD16+ Monocytes into LN
(A) Proportions of innate cells in LNs.
(B) Dot plot representation of CD14 and CD16
expression in monocyte subsets in LN. Graph
represents frequency of CD14+CD16+ monocytes
within all cells in LN.
(C) Pie charts show mean proportions of
the CD14+CD16 (blue), CD14+CD16+ (red),
CD14CD16 (green), and CD14dimCD16++ (gray)
cells within the total monocytes at baseline and
day 3; n = 5. Graph indicates proportion of
CD14+CD16+ cells within all monocytes in LN. In
(A)–(C), symbols represent individual animals in
the cohort.
(D) Histograms: monocyte expression of CD163
(left) and CD169 (right) at baseline (black), day 3
(green), day 5 (red, animal 1), day 7 (blue, animal
2), and isotype (gray) in two representative
animals.
(E) Mean fluorescent intensity of expression of
CD163 (left) and CD169 (right) at baseline (black)
and day 3 (red) postinfection; mean ± SEM (n = 5);
t test.
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Monocyte Stimulation of Plasmablasts during Dengueprimates (NHPs) with DENV and induce viral replication, specific
Ab response, lossof leucocytes, andhemorrhagicmanifestations.
Similar to the human disease, DENV infection augmented the
frequency or total bloodmonocytes between days 1 and 10 (Fig-
ures 6D and 6E). Moreover, infection increased the proportion of
blood pDC on day 3 after challenge (1.71-fold increase), but
there was no significant difference in the frequency of mDC (Fig-
ures 6D and S6B). As seen with human dengue (Figures 3C and
3D), there was an increase in the fraction of the CD14+CD16+
monocytes at 1–3 days after DENV challenge in NHPs (Figures
6E, 6F, and S6C).
Furthermore, infection with DENV induced an expansion of the
CD14+CD16+ monocyte subset in the secondary lymphoid or-
gans (Figure 7). At baseline (day 7) and 3 days after infection,
we collected inguinal and axillary lymph node (LN), respectively,Cell Host & Microbe 16, 115–to verify the local innate cellular compart-
ment (Figure 7A). Additionally, we
analyzed axillary LN from two individual
animals sacrificed on days 5 (n = 1) and
7 (n = 1) postinfection (Figure 6A). We de-
tected a substantial, 13-fold increase in
the absolute numbers of CD14+CD16+
cells that comprised a total of 0.32%–
0.44% of all cells in the axillary LNs of
three animals with the highest proportion
of total monocytes (Figure 7B). However,
even in the two animals (numbers 4
and 5) with lesser numbers of total tissue
monocytes, the CD14+CD16+ cells rep-
resented up to 11.1% of all monocytes,
significantly more than before the infec-
tion (Figure 7C).
We analyzed the phenotype of the
monocytes in LN by assessing surfaceexpression of CD163 and CD169, distinct markers for tissue sub-
capsular sinus macrophages (SSMs) (Junt et al., 2007; Martinez-
Pomares and Gordon, 2012) (Figure 7D). At baseline, all resident
monocytes expressed surface CD163; however, it was signifi-
cantlyupregulatedonday3after challenge,at thepeakexpansion
of the CD14+CD16+ subset in the axillary LN (Figures 7D and 7E).
Similarly, all tissue-resident monocytes upregulated expression
of CD169 at 3 days after infection as measured by mean fluores-
cent intensity (MFI) (Figures 7Dand7E). The surfaceexpressionof
CD163andCD169wasdiminishedat later timepoints (days 5 and
7), consistent with decreasing the quantity of the CD14+CD16+ in
the LNs as tested in the necropsy tissues collected from two
animals (Figure 7D). Taken together, these results demonstrate
that DENV infection of NHPs results in an expansion of the
CD14+CD16+ subset in secondary lymphoid organs and in blood.127, July 9, 2014 ª2014 Elsevier Inc. 123
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In this study, we performed a systems biological approach,
similar to that used to study immune responses to vaccination
in humans (Nakaya et al., 2011; Querec et al., 2009), to investi-
gate the early host response to dengue in humans. Previous
studies have used transcriptomic approaches to evaluate im-
mune responses to DENV infections (Devignot et al., 2010;
Hoang et al., 2010; Loke et al., 2010; Long et al., 2009; Popper
et al., 2012; Simmons et al., 2007; Ubol et al., 2008); however,
to the best of our knowledge to date, there has been no inte-
grated study of the cellular, transcriptional, and cytokine re-
sponses that underlie the innate response during acute dengue.
We demonstrate that the transcriptional response to dengue is
associated with both the VL and duration of illness. This is not
surprising, since the VL and NS-1 correlated with the days of
illness (fever days) reported by the patient at the time of sample
collection (Figures 1B and 1C). However, since patients’ reports
on the illness duration can be inaccurate, we classified our ana-
lyses on laboratory-tested values of VL and NS-1. Nevertheless,
an alternative analysis based on days of illness (Figure S1)
revealed results almost identical to those based on the viral
burden.
Consistent with other reports (Devignot et al., 2010; Loke et al.,
2010), we did not detect any difference in the transcriptional sig-
natures between patientswith DF andDHF (Figures 1D andS1A);
however, our cohort did not contain DSS cases, which show the
most variability in gene expression profiles among patients expe-
riencing different grades of dengue disease severity (Devignot
et al., 2010; Loke et al., 2010; Simmons et al., 2007). Moreover,
the lack of discrepancy between distinct dengue phenotypes
might also be attributed to the variation in viral burden and dura-
tion of the disease. The reports of reduced IFN-mediated
response in severe shock (DSS) patients suggest that DENV
can inhibit type I IFN signaling (Devignot et al., 2010; Popper
et al., 2012). Blockade of the efficient IFN response by DENV
(Schoggins et al., 2012) might be one of the mechanisms of pro-
gression into severe DHF/DSS symptoms. In fact, the NS-4B and
NS-5 proteins of DENV efficiently impede STAT signaling and
subsequent IFN-mediated response to infection (Ashour et al.,
2010; Mun˜oz-Jordan et al., 2003). Our experimental cohort
comprised uncomplicated cases of DFandDHF, andwe focused
our analysis on potential mechanisms of immune response to
dengue rather than on pathogenesis of DF/DHF and DSS.
A robust antibody production and plasmablast response is
one of the hallmarks of the immune response during dengue
(Beltramello et al., 2010; Wrammert et al., 2012), though the
mechanisms orchestrating such a response remain unclear.
Our analysis identified the intermediate CD14+CD16+ mono-
cytes as a one of most abundant blood phagocytes during acute
dengue in humans and blood and LN of infected NHP. However,
the fact that the numbers of CD14+CD16+ cells did not correlate
with Ab titers (data not shown), and numbers of plasmablasts
were higher in patients with low VL at late symptomatic disease
(Figures S2A and S2B) (Wrammert et al., 2012), is due to the
duration of symptomatic disease and different kinetics of these
cell subsets in blood.
Blood monocytes and tissue MQs were previously suggested
as a major reservoir for DENV replication (Durbin et al., 2008).124 Cell Host & Microbe 16, 115–127, July 9, 2014 ª2014 Elsevier InMoreover, monocytes are broadly decorated with Fc-g receptors
(Nimmerjahn andRavetch, 2008;Wong et al., 2011), a recognized
feature that contributes to ADE during secondary dengue (Hal-
stead et al., 2010). In fact, both the CD14+ and the nonclassical
CD14dimCD16+ cells can respond to DENV with a comparable ef-
ficiency and are equally susceptible for infection in vitro (Wong
et al., 2012). Though long considered as the transitional popula-
tion between the CD14+CD16 and CD14dimCD16++ cells, the
intermediate CD14+CD16+ monocytes represent a separate cell
population with distinct phenotype and molecular signature
(Cros et al., 2010; Wong et al., 2011). Of interest, we detected a
considerable proportion of the CD14+CD16+ cells in the LNs of
rhesus monkeys after DENV infection (Figures 7B and 7C), similar
to the animals immunized with TLR ligands (Kwissa et al., 2012).
These cells expressed high surface CD163 and CD169 (siglec-
1), a feature of the SSMs (Cyster, 2010; Martinez-Pomares and
Gordon, 2012). The subset of CD169+ SSM reside in the LN sinus
in the close proximity of migratory B cells (Carrasco and Batista,
2007;Cyster, 2010), cancaptureandpresent viral particles toanti-
viral B cells across the subcapsular sinus floor (Junt et al., 2007),
and drive antibody affinity maturation (Phan et al., 2009).
Relocation of the activated CD14+CD16+ cells demonstrating
characteristics of the CD163+CD169+ SSM may contribute to
the mechanisms driving a robust humoral response despite the
depletionofclassical BDCA-1+myeloidDCsduringacutedengue.
DENV stimulates IFN-I response in APC by inducing RIG-I and
MDA-5 (Loo et al., 2008; Nasirudeen et al., 2011), nucleic acid re-
ceptors commonly expressed by myeloid cells including mono-
cytes. Moreover, DENV has been previously shown to signal
through TLR3 (Nasirudeen et al., 2011; Tsai et al., 2009), though
monocytes weakly express TLR3 (Cros et al., 2010) and do not
respond to TLR3 agonists (Cros et al., 2010; Kadowaki et al.,
2001). However, distinct monocytes subsets express TLR7
and TLR8 (Cros et al., 2010), sensors of ssRNA that might be
involved in DENV recognition. Hence, DENV-mediated activation
of monocytes can be mediated by both RIG-I and MDA-5 and,
possibly, endogenous TLR signaling.
Dendritic cells and monocytes can stimulate B cells with the
BAFF- and APRIL-dependent mechanism (Litinskiy et al., 2002;
Mackay and Schneider, 2009). However, in contrast to the
study by Xu et al. (2012), where CD163+ human MQ efficiently
stimulated CD138++CD38++ plasma cells through the IP-10
(CXCL-10)- and IL-6-dependent mechanism, we did not observe
IL-6- and IP-10-dependent plasmablast stimulation and Ab pro-
duction (Figure S5). On the other hand, secretion of IgMand plas-
mablast differentiation were substantially reduced with a-BAFF,
TACI-Fc, anda-IL-10 treatment, similarly to the bloodmonocytes
conditioned with the serum from a patient with systemic lupus
erythematosus (SLE) (Joo et al., 2012). Hence, we attribute the
mechanism of plasmablast differentiation by DENV-infected
monocytes to BAFF/APRIL as well as IL-10 signaling.
In summary (Figure S7), we present a set of findings for dis-
secting the immunity to DENV infection. We determined that
the early host response to DENV infection is highly dependent
on the viral burden with inflammatory and IFN gene expression,
loss of myeloid DCs, and increase of the CD14+CD16+ mono-
cytes in blood and LN at the early phase of symptomatic disease,
followed by robust expansion of plasmablasts afterward. We
suggest a role of the CD14+CD16+ cells in supporting thec.
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ferentiation via BAFF/APRIL and IL-10. These resultsmay impact
further understanding of dengue pathogenesis and help in
discovering therapeutic and vaccination strategies.
EXPERIMENTAL PROCEDURES
Human Subjects and Specimen Collection
All studies were preapproved by the Faculty of Medicine at the Siriraj Hospital
and the Emory University institutional review boards. A single blood sample
was collected from patients diagnosed clinically with DENV infection admitted
to Siriraj Hospital in Bangkok, Thailand. The DENV infection was confirmed by
a serotype-specific RT-PCR from freshly isolated specimens as well as other
diagnostic tests, including NS-1 test, dengue-specific IgG and IgM ELISA or
dipstick tests, and DENV antigen-specific ELISPOT (Wrammert et al., 2012).
Days of febrile illness were reported by patients at the admission. Clinical
and laboratory patient data are described in the Supplemental Information
and summarized in Tables S1 and S2.
RNA Specimens and Gene Array Analysis
Whole blood was preserved on RNAlater buffer (Ambion). RNA was isolated
using the RiboPure-Blood Kit (Ambion), and alpha and beta globin mRNA
were depleted by GLOBINclear Kit (Ambion). Samples were checked for purity
and hybridized on Human U133 Plus 2.0 Arrays (Affymetrix). Microarray inten-
sity data of probe sets were normalized by RMA, which includes global back-
ground adjustment and quantile normalization. Probe sets representing the
same gene were collapsed by taking the probe set with the highest expression
across all samples. Hierarchical clustering and principal component analysis
(PCA) was performed using Spotfire (TIBCO Software). Pathway analyses
were performed using GSEA and Ingenuity Pathway Analysis (Ingenuity Sys-
tems) software. Detailed description of analyses can be found in the Supple-
mental Information.
Rhesus Animals and Infection
Five adult, Indian rhesus macaques (Macaca mulatta) were maintained at the
Yerkes National Primate Research Center (NPRC). Animals were cared for un-
der guidelines established by the Animal Welfare Act and the NIH ‘‘Guide for
the Care and Use of Laboratory Animals’’ with protocols approved by the
Emory University IACUC. NHP were age and weight matched and infected
by an intravenous (i.v.) injection with 2 3 107 plaque-forming units (pfu) of
DENV serotype 2, strain 16681 as described before (Onlamoon et al., 2010).
Animals were monitored daily for the onset of disease symptoms. Two individ-
ual animals were euthanized on days 5 and 7, respectively, for necropsy.
Flow Cytometry Analysis
For human samples, whole blood from patients was collected in CPT tubes
(Becton Dickinson, BD), and 100–200 ml was stained with an appropriate anti-
body cocktail. Cells were washed in PBS with 5% fetal bovine serum, and red
blood cells were lysed using the FACS lysis buffer (BD). Cells were washed and
fixed with the Cytofix buffer (BD) and analyzed on the FACSAria machine (BD).
Cell populations were defined within whole blood as represented in the Fig-
ure S3A, and the CD27++CD38++ plasmablast B cells were defined as
described before (Wrammert et al., 2012). Absolute cell counts were calcu-
lated using the complete blood counts. For NHP, PBMCs were isolated from
CPT tubes (BD) and LN were processed as described before (Kwissa et al.,
2012). The detailed staining procedures and list of antibodies are represented
in the Supplemental Information.
Viral Load and NS-1 Antigen
Plasma viral loads in human and NHP specimens were determined by the
quantitative RT-PCR, and the NS-1 antigen was measured by ELISA from
the cryopreserved samples. Detailed VL andNS-1 quantification are described
in the Supplemental Information.
Cytokines
Human plasma cytokines were analyzed using the Bio-Plex Pro Human Cyto-
kine 27-plex Assay (Bio-Rad) and are represented as pg/ml. APRIL and BAFFCellconcentrations were assessed by ELISA (eBioscience). Cytokines from cell
cultures were measured in supernatants in duplicates by BD Cytometric
Bead Array (BD) and analyzed on an LSRII (BD) instrument.
In Vitro Cell Assays
Studies with human blood cells were preapproved by the Emory University
institutional review board. PBMCs from a total of ten healthy donors were
purified from blood by a standard technique using LSM medium (MP Bio-
medicals). Monocytes were isolated by the positive selection using CD14
beads (Miltenyi Biotec), and B cells were isolated using the CD19 beads
(Miltenyi Biotec) to a purity of R95%. CD14+ monocytes or MDDCs were
infected with the DENV-2 (strain 16681) at moi = 1 for 48 hr. Resting, allo-
genic CD19+ B cells were stained with CFSE (Invitrogen) and cocultured in
96-well plates with the MDDCs or monocytes at the ratio of 5:1 in the pres-
ence of 20 U/ml of IL-2 (PeproTech) and 50 nM CpG type B 2006 (TriLink
Biotech) and blocking Ab. After 6 days, supernatants were collected for
IgG/A/M ELISA, and cells were stained with the appropriate Ab cocktail
and analyzed for CFSE dilution and B cell phenotype on a LSRII flow cytom-
eter (BD). Detailed conditions of assays are described in the Supplemental
Information.
Electron Microscopy
Plates were coated with Poly-L-Lysine (Sigma) according to the manufac-
turer’s protocol, and 5 3 105 of freshly isolated CD14+ monocytes were
infected with DENV-2 at moi = 1 or cultured with GM-CSF (1000 U/106 cells,
Miltenyi Biotec) and IL-4 (500 U/106, Peprotech) or M-CSF (200 ng/ml, Pepro-
tech) for 3 days. Preparation of the EM slides and imaging is describe in the
Supplemental Information.
Statistical Analyses
Analyses were done with GraphPad Prism. For clinical samples, analyses
between the groups were performed by ANOVA with Bonferroni’s correction.
For NHP, analysis shows significant change relevant to the baseline (day 7),
mean ± SEM, t test. Box bars show values between the first and the 99th
percentile, min/max. Correlation p values were calculated for efficiency.
Spearman’s rank correlation coefficient values are represented (r2). Diagonal
lines indicate linear regression. *p < 0.05, **p < 0.01, ***p < 0.001, ****p <
0.0001.
ACCESSION NUMBERS
The GEO accession number for the microarray data reported in this paper is
GSE51808.
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Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and four tables and can be found with this article online at
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